Recombinant Antithrombin (ATryn) to achieve >80% AT activity in pediatric and neonatal ECMO patients

Therapeutic area :

DeJongh J., Streisand J., Todd Tzanetos D., Fanning J. and Drenth H., Recombinant Antithrombin (ATryn) to achieve >80% AT activity in pediatric and neonatal ECMO patients. 26th Annual ELSO Conference.(2015) [Link to publication]